Regional reporting of adverse drug reactions:: A new computer-based network

被引:0
|
作者
Swoboda, WJ [1 ]
Göttler, M
Hasford, J
机构
[1] Univ Munich, Dept Neurol, D-80539 Munich, Germany
[2] Univ Munich, Dept Med Informat Biometry & Epidemiol, Pharmacoepidemiol Res Grp, Munich, Germany
关键词
adverse drug reaction (ADR); adverse event (AE); reporting; network; EUROSCAPE; EDIFACT; ICH; data security; digital signature;
D O I
10.1002/(SICI)1099-1557(199904)8:1+<S47::AID-PDS408>3.3.CO;2-C
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The use of drugs is always accompanied by the risk of adverse drug reactions (ADRs) and adverse events (AE). Generally physicians, pharmaceutical manufacturers, and pharmacists use a paper-based form for sending spontaneous ADR and AE reports to the national drug regulatory authority. Besides under-reporting, reporting lag-time and errors through data transformation are a major issue. In order to improve the current reporting situation we have set up a new computer-based, network-driven system for storing, transferring, and evaluating ADR reports. The system consists of three regional centres, one coordinating centre, and the central ADR database of the national drug regulatory authority. In the regional centres, clinical pharmacologists collect ADR data in local databases. There is a comfortable user-interface with an online help-function available. New reports are sent automatically to the Federal Agency using EUROSCAPE as a standardized electronic report form of the EU. The coordinating centre in Munich is responsible for overall performance and quality assurance. This model for a clinical health information network is of a high level of data security, is reliable and easily expandable through the use of standard tools, is fast and also inexpensive by using standard shareware products. Copyright (C) 1999 John Wiley & Sons, Ltd.
引用
收藏
页码:S47 / S53
页数:7
相关论文
共 50 条
  • [11] Reporting of adverse drug reactions
    Davies, Heather
    Noble, P. J.
    Pinchbeck, Gina
    Killick, David
    VETERINARY RECORD, 2019, 185 (14)
  • [12] REPORTING ADVERSE DRUG REACTIONS
    不详
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1966, 196 (05): : 429 - &
  • [13] Evaluation of a computer-based adverse-drug-event monitor
    Hwang, Soo-Hee
    Lee, Sukhyang
    Koo, Hyun-Kyung
    Kim, Yoon
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (23) : 2265 - 2272
  • [14] COMPUTER-BASED SYSTEM FOR ADVERSE DRUG REACTION DETECTION AND PREVENTION
    TATRO, DS
    MOORE, TN
    COHEN, SN
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1979, 36 (02): : 198 - 201
  • [15] Patient Reporting of Adverse Drug Reactions; Experience of Toulouse Regional Pharmacovigilance Center
    Chebane, L.
    Abadie, D.
    Bagheri, H.
    Durrieu, G.
    Montastruc, J. L.
    DRUG SAFETY, 2012, 35 (10) : 942 - 942
  • [16] Patient reporting of adverse drug reactions: experience of Toulouse regional pharmacovigilance center
    Abadie, D.
    Bagheri, H.
    Montastruc, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 37 - 37
  • [17] MANDATORY REPORTING OF ADVERSE DRUG REACTIONS
    Vaillancourt, Regis
    Gervais, Alan
    Gauthier, Claire
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2005, 58 : 32 - 32
  • [18] REPORTING ADVERSE DRUG-REACTIONS
    ROUJEAU, JC
    GUILLAUME, JC
    REVUZ, J
    TOURAINE, R
    LANCET, 1985, 2 (8466): : 1244 - 1244
  • [19] Reporting of adverse drug reactions by nurses
    Morrison-Griffiths, S
    Walley, TJ
    Park, BK
    Breckenridge, AM
    Pirmohamed, M
    LANCET, 2003, 361 (9366): : 1347 - 1348
  • [20] Adverse drug reactions - Is it worth reporting?
    O'Rourke, D.
    CATTLE PRACTICE, 2007, 15 : 234 - 239